Oxidative and inflammatory pathways

Oxidative and inflammatory pathways refer to a broad set of physiological and pathological processes rather than a single, well-defined molecular target. Oxidative stress occurs when the production of reactive oxygen species (ROS) exceeds the capacity of antioxidant defense systems, leading to cellular damage and contributing to diseases such as atherosclerosis and neurodegeneration (Source: NIH, PMC4055602). Inflammatory pathways involve complex signaling networks, including the activation of transcription factors like NF-κB, which regulate the expression of various pro-inflammatory cytokines and enzymes (Source: StatPearls, Chronic Inflammation). Because this term does not refer to a single protein or receptor, it is not considered a specific therapeutic target in modern drug discovery. Instead, it represents a complex network of interactions where drugs like general antioxidants or broad anti-inflammatory agents may exert effects across multiple molecular sites (Source: PubMed, PMID: 29065455). The lack of a defined molecular target makes it difficult to predict efficacy and safety profiles compared to targeted therapies. Furthermore, the interplay between oxidative stress and inflammation often creates a self-perpetuating cycle that exacerbates tissue injury in diseases like diabetes and chronic obstructive pulmonary disease (Source: PubMed, PMID: 24591303).

Other names

Unknown / non-specific oxidative and inflammatory pathwaysRedox-inflammatory signalingOxidative stress and inflammation

Non-specific reduction of reactive oxygen species and broad inhibition of pro-inflammatory signaling pathways.